Identification of Proteins Interacting with Human SP110 During the Process of Viral Infections

被引:46
作者
Cai, Lei [1 ,4 ]
Wang, Ying [2 ]
Wang, Jing-Fang [1 ,3 ,4 ]
Chou, Kuo-Chen [4 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China
[3] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China
[4] Gordon Life Sci Inst, San Diego, CA 92130 USA
基金
美国国家科学基金会;
关键词
Intracellular pathogen; mycobacterium tuberculosis; hepatic veno-occlusive disease; intracellular cancer; segment-docking; genetic/structural analysis; M2 PROTON CHANNEL; EPSTEIN-BARR-VIRUS; NUCLEAR-BODY; 3D STRUCTURE; PHD FINGER; DOMAIN; PREDICTION; INSIGHTS; ACTIVATION; PATTERNS;
D O I
10.2174/157340611794859343
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Human SP110 plays an important role in resisting intracellular pathogens, and hence has become an important drug target for preventing intracellular pathogen diseases, such as tuberculosis, hepatic veno-occlusive disease, and intracellular cancers. Unfortunately, so far little is known about the interactions of SP110 with the other proteins in a cell, which is considered to be the key for revealing its action mechanism and mediated pathway. Using both the genetic and structural analyses as well as the segment-docking approach, we have identified two proteins: the human remodeling and spacing factor 1 (RSF1) and the activating transcription factor 7 interacting protein (ATF7IP). They are very likely interacting with human SP110 during the process of viral infections. Owing to the close relationship of RSF1 with the chromatin remodeling and ATF7IP with the chromatin formation, it is logical to infer that human SP110 may be involved in the chromatin remodeling and formation as well. These findings may provide useful insights into the development of new drugs for treating and preventing intracellular pathogen diseases.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 41 条
[1]   Interrogating protein interaction networks through structural biology [J].
Aloy, P ;
Russell, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) :5896-5901
[2]   Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator [J].
Bloch, DB ;
Nakajima, A ;
Gulick, T ;
Chiche, JD ;
Orth, D ;
de la Monte, SM ;
Bloch, KD .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :6138-6146
[3]   The evolution of domain arrangements in proteins and interaction networks [J].
Bornberg-Bauer, E ;
Beaussart, F ;
Kummerfeld, S ;
Teichmann, S ;
Weiner, J .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (04) :435-445
[4]   NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1) [J].
Bottomley, MJ ;
Stier, G ;
Pennacchini, D ;
Legube, G ;
Simon, B ;
Akhtar, A ;
Sattler, M ;
Musco, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :11505-11512
[5]   The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation [J].
Bottomley, MJ ;
Collard, MW ;
Huggenvik, JI ;
Liu, ZH ;
Gibson, TJ ;
Sattler, M .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (07) :626-633
[6]   MYBBP1A: a new Ipr1's binding protein in mice [J].
Cai, Lei ;
Pan, Hui ;
Trzcinski, Krzysztof ;
Thompson, Claudette M. ;
Wu, Qiang ;
Kramnik, Igor .
MOLECULAR BIOLOGY REPORTS, 2010, 37 (08) :3863-3868
[7]   Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1 [J].
Chang, LK ;
Chung, JY ;
Hong, YR ;
Ichimura, T ;
Nakao, M ;
Liu, ST .
NUCLEIC ACIDS RESEARCH, 2005, 33 (20) :6528-6539
[8]   Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS [J].
Chou, KC ;
Wei, DQ ;
Zhong, WZ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (01) :148-151
[9]   Predicting protein-protein interactions from sequences in a hybridization space [J].
Chou, KC ;
Cai, YD .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (02) :316-322
[10]   Molecular therapeutic target for type-2 diabetes [J].
Chou, KC .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (06) :1284-1288